An early deficiency in Filaggrin (FLG) expression, mainly due to the genetic mutation of FLG-related genes, seems to be the initial driver of skin barrier disruption in AD, reducing the defensive mechanisms against antigens and allergens [42]. The gene discussed is FLG; the disease is Alzheimer disease.